Upload Avatar (500 x 500)
Peng Ke
pengke@wh.iov.cn
English, Chinese, German
Hubei
University of Chinese Academy of Sciences
Life Sciences
  • 2008-01--2012-03 PhD: Wageningen University, Netherlands
  • 2003-09--2007-12 PhD: Wuhan Institute of Virology, Chinese Academy of Sciences
  • 1998-09--2002-06 Bachelor's: Huazhong Agricultural University
  • 2012-04--2016-09 - Heidelberg University Medical School, Germany - Postdoctoral Researcher
  • Best Scientific Contribution Award (2014): Zurich, Switzerland
  • Presentation Award (2010): International Society for Invertebrate Pathology
Virus infection pathogenesis and antiviral drug research
  • SARS-CoV-2 Z-RNA activates the ZBP1-RIPK3 pathway to promote virus-induced inflammatory responses, Peng Ke, 2023
  • ACE2-independent infection of T lymphocytes by SARS-CoV-2, Peng Ke, 2022
  • Point-of-care test system for detection of immunoglobulin-G and-M against nucleocapsid protein and spike glycoprotein of SARS-CoV-2, Peng Ke, 2021
  • Antibody-dependent cellular cytotoxicity response to SARS-CoV-2 in COVID-19 patients, Peng Ke, 2021
  • High-Throughput Screening of an FDA-Approved Drug Library Identifies Inhibitors against Arenaviruses and SARS-CoV-2, Peng Ke, 2021
  • Effective virus-neutralizing activities in antisera from the first wave of survivors of severe COVID-19, Peng Ke, 2021
  • Trend of HIV-1 drug resistance in China: A systematic review and meta-analysis of data accumulated over 17 years (2001-2017) (vol 18, 100238, 2020), Peng Ke, 2021
  • Viral dynamics and antibody responses in people with asymptomatic SARS-CoV-2 infection, Peng Ke, 2021
  • Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension (vol 6, 96, 2020), Peng Ke, 2021
  • Temporal antibody responses to SARS-CoV-2 in patients of coronavirus disease 2019, Peng Ke, 2020
  • Virus-induced p38 MAPK activation facilitates viral infection, Peng Ke, 2020
  • SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation, Peng Ke, 2020
  • SFTSV Infection Induces BAK/BAX-Dependent Mitochondrial DNA Release to Trigger NLRP3 Inflammasome Activation, Peng Ke, 2020
  • Host factor heat-shock protein 90 contributes to baculovirus budded virus morphogenesis via facilitating nuclear actin polymerization, Peng Ke, 2019
  • NSs Filament Formation Is Important but Not Sufficient for RVFV Virulence In Vivo, Peng Ke, 2019
  • Dissecting the Cell Entry Pathway of Baculovirus by Single-Particle Tracking and Quantitative Electron Microscopic Analysis, Peng Ke, 2019
  • Calcium channel blockers reduce severe fever with thrombocytopenia syndrome virus (SFTSV) related fatality, Peng Ke, 2019
  • HIV-1 nuclear import in macrophages is regulated by CPSF6-capsid interactions at the nuclear pore complex, Peng Ke, 2019
  • Multiple Roles of HIV-1 Capsid during the Virus Replication Cycle, Peng Ke, 2019
  • The transmembrane nucleoporin Pom121 ensures efficient HIV-1 pre-integration complex nuclear import, Peng Ke, 2018
  • Quantitative microscopy of functional HIV post-entry complexes reveals association of replication with the viral capsid, Peng Ke, 2014
  • Characterization of Novel Components of the Baculovirus Per Os Infectivity Factor Complex, Peng Ke, 2012
  • In Situ Cleavage of Baculovirus Occlusion-Derived Virus Receptor Binding Protein P74 in the Peroral Infectivity Complex ▿, Peng Ke, 2011
  • Baculovirus Per Os Infectivity Factors Form a Complex on the Surface of Occlusion-Derived Virus ▿, Peng Ke, 2010
  • Identification of protein-protein interactions of the occlusion-derived virus-associated proteins of Helicoverpa armigera nucleopolyhedrovirus, Peng Ke, 2010
Virus Infection Pathogenesis Antiviral Drug Research Mechanism Therapy Sars-Cov-2 Hiv

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.